← back to search

Chandan Kanta Das

University of Pennsylvania · US
Area of research
Epidemiology · Oncology
Research interest
Research interests include Autophagy in Disease and Therapy, Epigenetics and DNA Methylation, Cancer-related Molecular Pathways, and Cancer, Hypoxia, and Metabolism.
h-index
17
citations
1,225
works
32
NIH funding
primary concept
email

Recent publications

NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis
Nature Genetics 2024cited by 29position: middledoi
Oncofusion-driven de novo enhancer assembly promotes malignancy in Ewing sarcoma via aberrant expression of the stereociliary protein LOXHD1
Cell Reports 2022cited by 19position: middledoi
Screening of the Prime bioactive compounds from Aloe vera as potential anti-proliferative agents targeting DNA
Computers in Biology and Medicine 2021cited by 29position: middledoi
Pro-survival autophagy and cancer cell resistance to therapy
Cancer and Metastasis Reviews 2018cited by 170position: firstdoi
BAG3 Overexpression and Cytoprotective Autophagy Mediate Apoptosis Resistance in Chemoresistant Breast Cancer Cells
Neoplasia 2018cited by 113position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Mahitosh Mandal · Virginia Commonwealth University3 papers (2018–2021)Donat Kögel · Goethe University Frankfurt2 papers (2018–2018) · 1 papers (2021–2021)Florian Bonn · Thermo Fisher Scientific (Germany)1 papers (2018–2018)Indranil Banerjee · Virginia Commonwealth University1 papers (2021–2021)Bikash Chandra Jena · Purdue University West Lafayette1 papers (2021–2021)Florencia Cidre‐Aranaz · German Cancer Research Center1 papers (2022–2022)Anjan K. Pradhan · Virginia Commonwealth University1 papers (2021–2021)Reyaz ur Rasool · UPMC Hillman Cancer Center1 papers (2022–2022)T. Grünewald · German Cancer Research Center1 papers (2022–2022) · 1 papers (2021–2021)Ramakrishnan Natesan · Amgen (United States)1 papers (2022–2022)Luni Emdad · Virginia Commonwealth University1 papers (2021–2021)Swadesh K. Das · University of Illinois Chicago1 papers (2021–2021) · 1 papers (2021–2021)T.S. Karin Eisinger‐Mathason · Cancer Research Institute1 papers (2022–2022)Patrick J. Grohar · Michigan State University1 papers (2022–2022)Benedikt Linder · Goethe University Frankfurt1 papers (2018–2018)Paul B. Fisher · Johnson Matthey (United Kingdom)1 papers (2021–2021)Zvi Cramer · McGill University Health Centre1 papers (2022–2022)